Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
51,368,292
-
Total 13F shares
-
16,487,274
-
Share change
-
+16,477,274
-
Total reported value
-
$165,856,000
-
Price per share
-
$10.06
-
Number of holders
-
38
-
Value change
-
+$165,755,000
-
Number of buys
-
37
Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q3 2019
As of 30 Sep 2019 Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) had 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,487,274 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, FRAZIER MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Novo Holdings A/S, ALLIANCEBERNSTEIN L.P., Rock Springs Capital Management LP, BAKER BROS. ADVISORS LP, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, and Alyeska Investment Group, L.P..
This table shows 38 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.